What is systemic scelrosis
Also known as scleroderma, is a chronic, autoimmune connective tissue disease characterized by:
Fibrosis of the skin and internal organs, vasculopathy, and immune system dysregulation
Two types of systemic sclerosis
Limited cutaneuous systemic scelrosis
Diffuse cutaenous systemic sclerosis
Pathophysiology
Vascular dysfunction: Endothelial cell injury and activation resulting in vasospasm, intimal proliferation, and obliteration of the vascular lumen.
This process contributes to the development of Raynaud’s phenomenon, digital ulcers, and pulmonary arterial hypertension
Immune dysregulation: Abnormal activation of the innate and adaptive immune systems, including T cells, B cells, and APCs, results in the production of autoantibodies and pro-inflammatory cytokines, which contribute to tissue damage and fibrosis
Fibrosis: Activation of fibroblasts and their differentiation into myofibroblasts lead to excessive deposition of ECM components, including collagen, in the skin and internal organs, causing tissue fibrosis and organ dysfunction
Clinical features - skin
Thickening, tightening, and hardening of the skin, which typically starts in the fingers and progresses proximally
Tight skin over the face
Small mouth
‘Beak’ nose
Clinical features - vascular
Vasospasm-induced color changes (pallor, cyanosis, and erythema) in the fingers and toes in response to cold or stress
Clinical features - GI
Dysphagia
Reflux
Hypomotility
Clinical features - Pulmonary
Interstitial lung disease (ILD)
Pulmonary arterial hypertension (PAH) are common complications, which can cause SOB, cough, and chest pain.
Clinical features - Renal
Scleroderma renal crisis, characterized by rapidly progressive renal failure and malignant hypertension
Life-threatening complication
Clinical feaures - MSK
Joint pain, stiffness, and contractures due to fibrosis of the joint capsules and tendons
What is limited cutaneous systemic sclerosis
Skin thickening is confined to areas distal to the elbows and knees
Often presents with Raynauds
Oragan involvement is less severe
High risk of pulmonary arterial HTN
What is CREST syndrome
Subtype of limited cutaneous
Calcinosis
Raynaud’s phenomenon
oEsophageal dysmotility
Sclerodactyly
Telangiectasia
What is diffuse cutaneous systemic scelrosis
Characterised by skin thickening that extends proximal to the elbows and knees
It can affect a large area of the body and progress rapidly
Internal organ involvement tends to be more severe
What investigations do you do
FBC - normocytic anaemia
Autoantibodies:
Anti-Scl-70 - associated with diffuse
Anticentromere - associated with limited
Nailfold capillaroscopy:
Abnormal capillary patterns, including dilatation, avascular areas, and neoangiogenesis
CT - to look for lung disease
Management
Organ based
Vasodilator therapy: Calcium channel blockers, phosphodiesterase-5 inhibitors, and prostacyclin analogues can help manage Raynaud’s phenomenon and digital ulcers, as well as pulmonary arterial hypertension
Immunosuppressive therapy: Corticosteroids, methotrexate, mycophenolate mofetil can be used to reduce inflammation and slow the progression of fibrosis
Gastrointestinal management: PPIs
Renal management: Prompt treatment with ACEIs is crucial in the management of renal crisis
Physical therapy and occupational therapy: These interventions can help maintain joint mobility, improve muscle strength, and address functional limitations.
What is Raynauds phenomenon
Exaggerated vasoconstrictive response of the digital arteries and cutaneous arteriole to the cold or emotional stress
It may be primary (Raynaud’s disease) or secondary (Raynaud’s phenomenon).
Causes of secondary Raynauds phenomenon
CT disorders
Scleroderma
RA
SLE
Leukaemia
Use of vibrating tools
Ooral contraceptive pill
cervical rib